Text this: Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for <i>Clostridioides difficile</i> Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective